|

Obeticholic Acid Clinical Trials

1 actively recruiting trial across 1 location

Also known as: INT-747, Ocaliva

Pipeline

Phase 2: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Esophageal Adenocarcinoma1
  • Barrett Esophagus1
  • Cancer1

Kansas City, Kansas1 trial

Obeticholic Acid for Prevention in Barrett's Esophagus

University of Kansas Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.